Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - WILLIS TOWERS WATSON PLC

23rd Apr 2021 13:35

 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing22 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD
LongShort

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,715,206

1.33%

165,818

0.13%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

7,134

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

(4)

TOTAL:

 

 

 

 

1,793,665

1.39%

179,052

0.14%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

4

233.6450 USD
Purchase

4

233.7000 USD
Purchase

5

233.4960 USD
Purchase

12

233.4016 USD
Purchase

16

233.5887 USD
Purchase

16

233.4475 USD
Purchase

16

233.5100 USD
Purchase

52

233.4828 USD
Purchase

97

233.5800 USD
Purchase

100

233.4200 USD
Purchase

100

233.3800 USD
Purchase

100

232.9900 USD
Purchase

200

233.3000 USD
Purchase

200

233.0400 USD
Purchase

200

234.4160 USD
Purchase

259

234.1744 USD
Purchase

400

233.1550 USD
Purchase

600

234.3650 USD
Purchase

654

233.7466 USD
Purchase

816

233.4186 USD
Purchase

918

233.6244 USD
Purchase

975

233.9806 USD
Purchase

1,012

233.1876 USD
Purchase

1,312

233.6223 USD
Purchase

1,570

233.3229 USD
Purchase

2,210

233.1500 USD
Purchase

5,796

233.1735 USD
Purchase

5,935

233.6948 USD
Purchase

7,486

233.6114 USD
Purchase

27,569

233.7639 USD
Sale

3

233.5433 USD
Sale

52

233.7803 USD
Sale

100

234.3900 USD
Sale

100

234.4160 USD
Sale

304

233.3262 USD
Sale

401

233.4549 USD
Sale

571

233.9463 USD
Sale

671

234.2771 USD
Sale

690

233.1990 USD
Sale

971

233.9827 USD
Sale

1,107

233.2089 USD
Sale

1,159

233.2919 USD
Sale

2,229

233.1500 USD
Sale

5,656

233.7346 USD
Sale

5,796

233.1735 USD
Sale

8,740

233.5914 USD
Sale

30,084

233.7438 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?YES
Date of disclosure:23 Apr 2021
Contact name:Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product nameWritten orNumber ofExerciseTypeExpiry
purchasedrelevant securitiespricedate
to which the option
or derivative

relates

 

 

 

Put OptionsPurchased

-100

220.0000

American

Jul 16, 2021

Call OptionsPurchased

100

240.0000

American

Jul 16, 2021

Call OptionsPurchased

6,000

220.0000

American

Jul 16, 2021

Put OptionsPurchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210423005312/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,837.91
Change26.87